Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
20.12.2018 14:30:00

CynergisTek and Protenus Join Forces as Partners to Protect Patient Privacy

CynergisTek, Inc. (NYSE AMERICAN: CTEK), a leader in healthcare cybersecurity, privacy, and information assurance, today announced it has formed a preferred partnership with Protenus, a healthcare compliance analytics platform that protects patient privacy, to help health systems nationwide enhance patient privacy monitoring programs. The partnership will grant health systems access to Protenus’ robust analytics that leverages artificial intelligence to gather data related to potential patient privacy risks, along with CynergisTek’s Patient Privacy Monitoring Service, a managed service offering designed to implement and maintain an effective privacy monitoring analytics program with skilled privacy resources.

According to the Protenus Breach Barometer, insider incidents accounted for 23 percent of all breaches that occurred at health systems in Q3 2018. This figure will only continue increasing, indicating that now more than ever, health systems need a cost-effective solution to meet the daily challenges of managing patient privacy. To address this need, CynergisTek and Protenus formed a preferred partnership to combine CynergisTek’s industry experience in healthcare consulting and optimization of privacy programs with Prontenus’ strength in healthcare analytics technology to offer health systems both the people, processes, and technology components of a strong patient privacy monitoring program.

"As health systems face mounting challenges in creating and maintaining robust patient privacy monitoring programs, we identified a need to partner with a company offering complementary services so that health systems can act on the insights uncovered by our analytics,” said Nick Culbertson, CEO and Co-Founder of Protenus. "With a long-standing reputation as one of the leading authorities on healthcare security and privacy, we are confident that combining our technology with CynergisTek’s know-how will push the industry forward when it comes to making patient privacy a priority.”

"Data privacy is evolving as a dominate theme in conversations, both in healthcare and other industries, and health systems need to take an end-to-end approach to patient privacy to truly address this complex and mission-critical challenge,” said Mac McMillan, CEO and President of CynergisTek. "We’re honored to be entering a partnership with Protenus as we’ve long admired the robust capabilities of its AI-powered analytics and believe that by pairing our expertise and services with its proven technology, we will be able to help our clients develop the most resilient patient privacy programs possible.”

About Protenus

The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting privacy, security and compliance teams to inappropriate activity, Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Learn more at Protenus.com and follow us on Twitter @Protenus.

About CynergisTek, Inc.

CynergisTek is a top-ranked cybersecurity firm dedicated to serving the information assurance needs of the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve security, privacy, compliance, and document output goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been recognized by KLAS in the 2016 and 2018 Cybersecurity reports as a top performing firm in healthcare cybersecurity as well as the 2017 Best in KLAS winner for Cybersecurity Advisory Services.

Forward-Looking Statements

This release contains certain forward-looking statements relating to the business of CynergisTek that can be identified by the use of forward-looking terminology such as "believes,” "expects,” "anticipates,” "may” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product/service development, long and uncertain sales cycles, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, future capital requirements, competition from other providers, the ability of our vendors to continue supplying the company with equipment, parts, supplies and services at comparable terms and prices and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Some of these risks and uncertainties are or will be described in greater detail in our Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Nachrichten zu Auxilio Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Auxilio Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!